Janux Therapeutics: Wedbush boosts target to $53 from $24
Analyst Coverage Wedbush raised the 12 month target forecast on Janux’s stock to $53 from $24 signals Wedbush’s conviction in the company’s…
Browse research
Tag: analyst ratings
Viking Therapeutics: Analyst Rate as a “Consensus Strong Buy”
Viking Therapeutics Inc: A Stock Forecast Analysis Viking Therapeutics Inc, a biopharmaceutical company focused on the development of novel therapies for metabolic…
249 Analyst Ratings for Tuesday February 27th, 2024
Analyst Ratings Name Symbol Analyst Action Rating Target Price Aurora Cannabis Inc ACB:CA Jefferies & Company Target Down Hold 4.95 Acco Brands…
Stock Market Update for February 27th, 2024
Global Markets Japanese Markets In Japan, the Nikkei average concluded the trading session nearly unchanged, indicating minimal movement in overall market sentiment.…
AMC Entertainment Braces for Q4 Earnings Amidst Stock Volatility
AMC Entertainment (AMC: NYE) gears up for its Q4 2023 earnings release. The company’s stock price has been volatile due to its…